BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35916738)

  • 21. Evaluation of salivary oxidate stress biomarkers, nitric oxide and C-reactive protein in patients with oral lichen planus and burning mouth syndrome.
    Tvarijonaviciute A; Aznar-Cayuela C; Rubio CP; Ceron JJ; López-Jornet P
    J Oral Pathol Med; 2017 May; 46(5):387-392. PubMed ID: 27862315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peripheral nervous system involvement in primary burning mouth syndrome--results of a pilot study.
    Puhakka A; Forssell H; Soinila S; Virtanen A; Röyttä M; Laine M; Tenovuo O; Teerijoki-Oksa T; Jääskeläinen SK
    Oral Dis; 2016 May; 22(4):338-44. PubMed ID: 26847146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationships between oral MUC1 expression and salivary hormones in burning mouth syndrome.
    Kang JH; Kim YY; Chang JY; Kho HS
    Arch Oral Biol; 2017 Jun; 78():58-64. PubMed ID: 28199919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Saliva flow rates and clinical characteristics of patients with burning mouth syndrome: A case-control study.
    Werfalli S; Drangsholt M; Johnsen JM; Jeffrey SK; Dakhil S; Presland RB; LeResche L
    Int J Oral Maxillofac Surg; 2021 Sep; 50(9):1187-1194. PubMed ID: 33640241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Time-course of pain and salivary opiorphin release in response to oral capsaicin differ in burning mouth syndrome patients, temporomandibular disorders patients and control subjects.
    Alajbeg IZ; Vrbanovic E; Alajbeg I; Orabovic I; Naka K; Mrla A; Boucher Y
    Clin Oral Investig; 2024 Apr; 28(5):246. PubMed ID: 38589630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathophysiology of primary burning mouth syndrome with special focus on taste dysfunction: a review.
    Kolkka-Palomaa M; Jääskeläinen SK; Laine MA; Teerijoki-Oksa T; Sandell M; Forssell H
    Oral Dis; 2015 Nov; 21(8):937-48. PubMed ID: 25962669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MUC1 and Toll-like receptor-2 expression in burning mouth syndrome and oral lichen planus.
    Kho HS; Chang JY; Kim YY; Kim Y
    Arch Oral Biol; 2013 Jul; 58(7):837-42. PubMed ID: 23411403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The social context of burning mouth syndrome: an exploratory pilot study of stigma, discrimination, and pain.
    Mathur VA; Payano Sosa JS; Keaser ML; Meiller TF; Seminowicz DA
    Pain Med; 2023 Nov; 24(11):1213-1218. PubMed ID: 37314981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salivary interleukin-6 and tumor necrosis factor-alpha in patients with burning mouth syndrome.
    Boras VV; Brailo V; Lukac J; Kordić D; Blazić-Potocki Z
    Oral Dis; 2006 May; 12(3):353-5. PubMed ID: 16700748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of burning mouth syndrome profiles based on response to a local anaesthetic lozenge.
    Treldal C; Petersen J; Mogensen S; Therkildsen C; Jacobsen J; Andersen O; Pedersen AML
    Oral Dis; 2020 Apr; 26(3):656-669. PubMed ID: 31880064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Candidiasis and Other Bacterial Infections among Patients Diagnosed with Burning Mouth Syndrome.
    Jankovskis V; Selga G
    Medicina (Kaunas); 2022 Aug; 58(8):. PubMed ID: 36013496
    [No Abstract]   [Full Text] [Related]  

  • 32. Protein composition, adhesion, and agglutination properties of saliva in burning mouth syndrome.
    Tammiala-Salonen T; Söderling E
    Scand J Dent Res; 1993 Aug; 101(4):215-8. PubMed ID: 8362199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced sialyl-Lewis
    Acharya S; Jin C; Bylund J; Shen Q; Kamali-Moghaddam M; Jontell M; Carlén A; Karlsson NG
    Mol Omics; 2019 Oct; 15(5):331-339. PubMed ID: 31414088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comprehensive analysis of the oral microbiota and metabolome change in patients of burning mouth syndrome with psychiatric symptoms.
    Luo S; Lou F; Yan L; Dong Y; Zhang Y; Liu Y; Ji P; Jin X
    J Oral Microbiol; 2024; 16(1):2362313. PubMed ID: 38835338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcitonin gene-related peptide levels in saliva of patients with burning mouth syndrome.
    Zidverc-Trajkovic J; Stanimirovic D; Obrenovic R; Tajti J; Vécsei L; Gardi J; Németh J; Mijajlovic M; Sternic N; Jankovic L
    J Oral Pathol Med; 2009 Jan; 38(1):29-33. PubMed ID: 19192048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biochemical analysis of saliva and taste acuity evaluation in patients with burning mouth syndrome, xerostomia and/or gustatory disturbances.
    Hershkovich O; Nagler RM
    Arch Oral Biol; 2004 Jul; 49(7):515-22. PubMed ID: 15126133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Taste and Pain Response in Burning Mouth Syndrome With and Without Geographic Tongue.
    Su N; Poon R; Liu C; Dewan C; Darling M; Grushka M
    J Oral Facial Pain Headache; 2020 Summer; 34(3):217-221. PubMed ID: 32870950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Burning mouth syndrome and burning mouth in hypothyroidism: proposal for a diagnostic and therapeutic protocol.
    Femiano F; Lanza A; Buonaiuto C; Gombos F; Nunziata M; Cuccurullo L; Cirillo N
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jan; 105(1):e22-7. PubMed ID: 18155597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Salivary cortisol, 17β-estradiol, progesterone, dehydroepiandrosterone, and α-amylase in patients with burning mouth syndrome.
    Kim HI; Kim YY; Chang JY; Ko JY; Kho HS
    Oral Dis; 2012 Sep; 18(6):613-20. PubMed ID: 22533537
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.